Other versions:

(Verbatim name)

ID

(Catalog Number)

ORG

DES

Invalid DOI was provided, please try again

XML
PDF
 
 
Bluesky
Twitter
Facebook
Telegram
Mendeley
Reddit
Notify a colleague
  • ContentsContents
  • Article InfoArticle Info
  • CiteCite
  • MetricsMetrics
  • CommentComment
  • RelatedRelated
  • FigsFigs
  • TabsTabs
  • RefsRefs
  • CitedCited
  • Article title
  • Abstract
  • Keywords
  • Introduction
  • Aim of the study
  • Patients and methods
  • Eligibility criteria
  • Exclusion criteria
  • Study procedure
  • Data analysis
  • Results
    • Descriptive statistics
    • The differential diagnosis of the study group
    • Activated partial thromboplastin time (aPTT) level
    • Intravenous UFH administration versus subcutaneous administration
    • Clinical pharmacist interventions
  • Discussion
  • Conclusion
  • Limitations of the study
  • Additional information
  • References
Subscribe to email alerts for current Article's categories
Powered by